Mometahexal (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometahexal, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal and perennial forms, and nasal polyps in adults and children.

GNH USA supplies Mometahexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray is a glucocorticoid used to manage inflammatory conditions of the nasal passages.

- Allergic rhinitis: reduces nasal congestion, itching and sneezing caused by allergic inflammation. - Seasonal allergic rhinitis: alleviates symptoms that flare during specific pollen seasons. - Perennial allergic rhinitis: controls year‑round nasal symptoms from continuous allergen exposure. - Nasal polyps: helps shrink polyps and improve nasal airflow.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleeds). - Throat irritation or dryness. - Cough. - Altered taste or bitter taste.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes or cataract formation. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal passages.

Before initiating therapy, consider the following precautions.

- Assess for active nasal infection: avoid use until infection resolves. - Recent nasal surgery or trauma: postpone treatment to prevent impaired healing. - Do not exceed prescribed dose: higher doses increase risk of systemic effects. - Monitor for signs of systemic corticosteroid exposure, such as bruising or mood changes. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone furoate nasal spray can interact with other medicines.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic steroid levels. - Systemic corticosteroids: additive immunosuppressive effects. - Live vaccines: reduced vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., itraconazole): may increase local exposure. - Ritonavir or other protease inhibitors: may elevate steroid concentrations. - St. John’s wort: may decrease steroid effectiveness.